These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31274080)

  • 61. Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer.
    Ivliev AE; 't Hoen PA; Borisevich D; Nikolsky Y; Sergeeva MG
    PLoS One; 2016; 11(11):e0165059. PubMed ID: 27824868
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The promise of genomics-based drug repurposing.
    Dudley J
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):601-3. PubMed ID: 25654481
    [No Abstract]   [Full Text] [Related]  

  • 63. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
    Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
    Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathway-based Bayesian inference of drug-disease interactions.
    Pratanwanich N; Lió P
    Mol Biosyst; 2014 Jun; 10(6):1538-48. PubMed ID: 24695945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Applications of chemogenomic library screening in drug discovery.
    Jones LH; Bunnage ME
    Nat Rev Drug Discov; 2017 Apr; 16(4):285-296. PubMed ID: 28104905
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Changes on the Horizon for Drug Repurposing, Rescue, and Repositioning at ASSAY.
    Melancon BJ; Mucke HAM
    Assay Drug Dev Technol; 2018; 16(4):193. PubMed ID: 29870272
    [No Abstract]   [Full Text] [Related]  

  • 67. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Computational drug repurposing to predict approved and novel drug-disease associations.
    Khalid Z; Sezerman OU
    J Mol Graph Model; 2018 Oct; 85():91-96. PubMed ID: 30130693
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
    Sun P; Guo J; Winnenburg R; Baumbach J
    Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-Cancer Drug Repurposing Candidates for Renal Cell Carcinoma.
    Au L; Koudijs KKM; Terwisscha van Scheltinga AGT; Guchelaar HJ
    Cancer J; 2019; 25(2):147-148. PubMed ID: 30896538
    [No Abstract]   [Full Text] [Related]  

  • 71. A Practical Guide for Exploring Opportunities of Repurposing Drugs for CNS Diseases in Systems Biology.
    Mei H; Feng G; Zhu J; Lin S; Qiu Y; Wang Y; Xia T
    Methods Mol Biol; 2016; 1303():531-47. PubMed ID: 26235090
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predicting drug-disease associations and their therapeutic function based on the drug-disease association bipartite network.
    Zhang W; Yue X; Huang F; Liu R; Chen Y; Ruan C
    Methods; 2018 Aug; 145():51-59. PubMed ID: 29879508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases.
    Berenstein AJ; Magariños MP; Chernomoretz A; Agüero F
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004300. PubMed ID: 26735851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug repurposing in chemical genomics: can we learn from the past to improve the future?
    Bisson WH
    Curr Top Med Chem; 2012; 12(17):1883-8. PubMed ID: 23116467
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A perspective on genomic-guided anthelmintic discovery and repurposing using Haemonchus contortus.
    Preston S; Jabbar A; Gasser RB
    Infect Genet Evol; 2016 Jun; 40():368-373. PubMed ID: 26144657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Network-based drug repositioning: A novel strategy for discovering potential antidepressants and their mode of action.
    Zhang TT; Xue R; Wang X; Zhao SW; An L; Li YF; Zhang YZ; Li S
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1137-1150. PubMed ID: 30087074
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
    Pulley JM; Shirey-Rice JK; Lavieri RR; Jerome RN; Zaleski NM; Aronoff DM; Bastarache L; Niu X; Holroyd KJ; Roden DM; Skaar EP; Niswender CM; Marnett LJ; Lindsley CW; Ekstrom LB; Bentley AR; Bernard GR; Hong CC; Denny JC
    Assay Drug Dev Technol; 2017 Apr; 15(3):113-119. PubMed ID: 28379727
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Repositioning Natural Products in Drug Discovery.
    Rastelli G; Pellati F; Pinzi L; Gamberini MC
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32143476
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical Trials of Repurposing Medicines in Acute Myeloid Leukemia: Limitations and Possibilities in the Age of Precision Therapy.
    Andresen V; Gjertsen BT
    Cancer J; 2019; 25(2):153-163. PubMed ID: 30896540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.